STOCK TITAN

CRH Medical Corporation Comments on Recently Passed Billing Legislation

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

CRH Medical Corporation (CRHM) has commented on the recently passed COVID-19 relief bill, which includes significant surprise billing legislation effective in 2022. This new law features a 30-day negotiation period for out-of-network claims, followed by third-party arbitration if negotiations fail. Notably, arbitrators will not consider geographic benchmarks or Medicare and Medicaid rates. CEO Dr. Tushar Ramani expressed optimism that these changes will enhance payor negotiations, thereby reducing non-contracted revenue exposure, which could positively impact future revenue and profit visibility for CRH.

Positive
  • Surprise billing legislation could enhance contracting negotiations with payors.
  • The new law aims to minimize non-contracted revenue exposure, positively impacting future revenue.
Negative
  • None.

VANCOUVER, BC, Dec. 22, 2020 /PRNewswire/ - CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) today commented on the COVID-19 relief bill passed yesterday by the United States Congress.

Lawmakers included the long-awaited surprise billing legislation into the relief bill. The surprise billing legislation has three important components that are scheduled to go into effect in 2022:

  • The legislation allows for a 30-day period whereby the insurer and provider can negotiate payment for any out-of-network claims.

  • If these negotiations are not successful, then the next step would be third-party arbitration.

  • In the event of arbitration, an arbitrator is not required to consider a geographic benchmark payment level, and is prohibited from factoring in Medicare and Medicaid rates when determining out-of-network payment.

"We expect the provider-friendly language of the recently passed surprise billing legislation will serve to meaningfully advance our contracting negotiations with payors in a manner that will more fairly reflect the value of the services we provide to our patients," noted Dr. Tushar Ramani, Chief Executive Officer of CRH. "As a reminder, our payor contracting effort is a key part of our larger strategy to minimize our non-contracted revenue exposure, which we view as positively impacting future revenue and profit visibility."

About CRH Medical Corporation:

CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. To date, CRH has completed 31 anesthesia acquisitions, and now serves 68 ambulatory surgical centers in 13 states. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves. CRH's O'Regan System is currently used in all 48 lower US states.

Cision View original content:http://www.prnewswire.com/news-releases/crh-medical-corporation-comments-on-recently-passed-billing-legislation-301197592.html

SOURCE CRH Medical Corporation

FAQ

What is CRH Medical Corporation's response to the surprise billing legislation?

CRH Medical Corporation believes the new surprise billing legislation will advance their contracting negotiations with payors.

When will the surprise billing legislation take effect?

The surprise billing legislation is scheduled to go into effect in 2022.

What are the key components of the surprise billing legislation?

The law includes a 30-day negotiation period for out-of-network claims, third-party arbitration if negotiations fail, and specific rules on arbitration considerations.

How might the new billing legislation affect CRH Medical Corporation's revenue?

The legislation is expected to reduce non-contracted revenue exposure for CRH, potentially improving future revenue and profit visibility.

CRHM

NYSE:CRHM

CRHM Rankings

CRHM Latest News

CRHM Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Canada
Vancouver